International Tax Review is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 33,343 results that match your search.33,343 results
  • International business expansions can substantially increase the bottom line, but this outcome is largely dependent on establishing an efficient structure that helps to ensure financial success. Lee Sheehan, head of tax at Radius, looks at the importance of a clear strategy when setting up tax structures for specific business locations, and points out some of the landmines to avoid along the way.
  • Publicly-traded companies seemingly have an affinity towards Ireland. Is it purely a pursuit of the Emerald Isle’s temperate climate that attracts them? Conor Hurley and Ailish Finnerty of Arthur Cox analyse the factors influencing taxpayer decisions to locate in Ireland, debunking the idea that such decisions are solely tax-driven.
  • Read this month's special features on Germany, Ireland, Mexico and tax technology.
  • See who has done the tax work on this month’s biggest deals.
  • Mateusz Szczurek, Poland's finance minister, has announced the government's intention to lower the VAT rate from 23% to 22% by 2016, a year earlier than originally planned.
  • US businesses will be pleased that lawmakers have taken one step closer to providing certainty over the future of the R&D tax credit, after the House of Representatives voted 274-131 to approve legislation that would permanently extend the provision.
  • A spate of recent examples indicates that inversion transactions are as popular as they have ever been, with Pfizer’s attempted deal with AstraZeneca highlighting that companies in the pharmaceuticals industry are increasingly using the inversion option. William Fry Tax Advisors, the Irish member firm of Taxand, look at why this is, and analyse why Ireland is proving to be the location of choice for newly-formed companies post-inversion.
  • Business news has been dominated in the past month by the bid for AstraZeneca from US pharmaceuticals company Pfizer, so it is appropriate that this month's cover story takes an in-depth look at the popularity of inversion transactions, from what motivates such transactions to what countries such as the US intend to do about the increasing migration of multinationals out of their jurisdiction and out of their tax net.
  • Tax reform, the Supreme Court and the OECD’s BEPS project mean that tax risk management will only get more important for Mexican taxpayers, believes David Franco, of Maplecroft.
  • There may be tax traps associated with making an investment into China via foreign intermediaries, but KPMG’s Abe Zhao and Conrad Turley show that, with sufficient advance planning, taxpayers can avail themselves of treaty relief measures.